Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: Analysis of single-agent and combined modality approaches

por Beal, Kathryn, Abrey, Lauren E, Gutin, Philip H
Publicado 2011

Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors

por Armand, Jean-Pierre, Ribrag, Vincent, Harrousseau, Jean-Luc, Abrey, Lauren
Publicado 2007

Diagnosis and management of primary intraocular lymphoma: an update

por Jahnke, Kristoph, Thiel, Eckhard, Abrey, Lauren E, Neuwelt, Edward A, Korfel, Agnieszka
Publicado 2007

Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials

por Han, Kelong, Ren, Melanie, Wick, Wolfgang, Abrey, Lauren, Das, Asha, Jin, Jin, Reardon, David A.
Publicado 2014

Interpretation of meta-analysis evaluating progression-free survival as a surrogate endpoint for overall survival in glioblastoma

por Han, Kelong, Ren, Melanie, Wick, Wolfgang, Abrey, Lauren, Das, Asha, Jin, Jin, Reardon, David A.
Publicado 2015

Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy

por Chinot, Olivier L., Macdonald, David R., Abrey, Lauren E., Zahlmann, Gudrun, Kerloëguen, Yannick, Cloughesy, Timothy F.
Publicado 2013

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma

por Kaley, Thomas J., Panageas, Katherine S., Pentsova, Elena I., Mellinghoff, Ingo K., Nolan, Craig, Gavrilovic, Igor, DeAngelis, Lisa M., Abrey, Lauren E., Holland, Eric C., Omuro, Antonio, Lacouture, Mario E., Ludwig, Emmy, Lassman, Andrew B.
Publicado 2020